Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial von White, Harvey D, Steg, Ph Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Erglis, Andrejs, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lopes, Renato D, Mahaffey, Kenneth W, Moryusef, Angele, Pordy, Robert, Roe, Matthew T, Sritara, Piyamitr, Tricoci, Pierluigi, Zeiher, Andreas M, Schwartz, Gregory G

Volltext

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome von Schwartz, Gregory G, Steg, P. Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J. Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Pordy, Robert, Quintero, Kirby, Roe, Matthew T, Sasiela, William J, Tamby, Jean-François, Tricoci, Pierluigi, White, Harvey D, Zeiher, Andreas M

Volltext

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES r... von Harrington, Robert A, Pordy, Robert, Bhatt, Deepak L., Moryusef, Angèle, Sinnaeve, Peter, Pećin, Ivan, Novaretto, Leonardo P., Codutti, Oscar R., Vico, Marisa L., Bustamante Labarta, Miguel H, Arstall, Margaret A, Garrahy, Paul J, Wollaert, Bart, Kulić, Mehmed, Eliaschewitz, Freddy G, Kaiser, Sergio, Manenti, Euler Roberto Fernandes, Vuurmans, Tycho, Lai, Christopher, Olivares, Claudia, Chen, Jiyan, Huang, Weijian, Li, Xiang, Cheng, Xiaoshu, Wei, Meng, Fan, Zhongcai, Accini Mendoza, Jose L, Ghlonti, Ramaz, Schmidt, Ekkehard, Patsilinakos, Sotiris, Fausto Ovando, Sergio R, Yan, Bryan PY, Merkely, Bela, Premchand, Rajendra K, Kerkar, Prafulla, Patil, Sachin N, Chopda, Manoj, Chopra, Vijay K, Kumar, Vinay, Marco, Valgimigli, Cuccia, Claudio, Ferratini, Maurizio, Doi, Yasuji, Uematsu, Masaaki, Kim, Chongjin, Liew, Houng B, Llamas Esperón, Guillermo Antonio, Suarez Otero, Rodrigo, Kaplan, Refik, Gosselink, Antonius TM, Castillo Leon, Reynaldo P, Hernandez Zuniga, Jose D, Camacho Cosavalente, Luis A, Rodriguez Chavez, Víctor E, Wlodarczak, Adrian, Jaworska, Krystyna, Kubica, Jacek, Tesloianu, Dan N, Constantinescu, Mircea CA, Vishnevsky, Alexander Y, Povzun, Anton, Kanorsky, Sergey, Reuter, Helmuth, Cruz Fernández, Jose M, Worner Diz, Fernando, Bruguera Cortada, Jordi, Valdivielso, Pedro, Ponnamperuma, Chandrike, Huang, Tsuei-Yuan, Sukonthasarn, Apichard, Sansanayudh, Nakarin, Kehasukcharoen, Wirash, Ural, Ertan, Karpenko, Oleksandr, Mostovoy, Yuriy, Malynovsky, Yaroslav, Kopytsya, Mykola, Yagensky, Andriy, Griffiths, Huw, Kurian, John, Palmer, Bruce, White, Lindsey, Klancke, Kim, Waider, Winfried, Henderson, David, Mody, Freny, Park, Hyeun (Tom), Vidovich, Mladen, Rozeman, Phillip, Espinoza, Andrey, Pereira, Edward, Spriggs, Douglas, Nahhas, Ahed, Sharma, Mukesh, Bayron, Carlos, Gilmore, Richard, Ball, Eric, Mrabti, Asmaa, Kralova, Katarina, Etienne, Alexis

Volltext

Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes The ODYSSEY OUTCOMES Trial von Bhatt, Deepak L., Briggs, Andrew H., Reed, Shelby D., Annemans, Lieven, Szarek, Michael, Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Higuchi, Keiko, Joulain, Florence, Jukema, J. Wouter, Li, Qian H., Mahaffey, Kenneth W., Sanchez, Robert J., Roe, Matthew T., Lopes, Renato D., White, Harvey D., Zeiher, Andreas M., Schwartz, Gregory G., Steg, Ph. Gabriel

Volltext

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol von Schwartz, Gregory G., Szarek, Michael, Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Jukema, J. Wouter, Landmesser, Ulf, Lopez-Jaramillo, Patricio, Manvelian, Garen, Pordy, Robert, Scemama, Michel, Sinnaeve, Peter R., White, Harvey D., Steg, Ph Gabriel

Volltext

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab von Hagström, Emil, Steg, P. Gabriel, Szarek, Michael, Bhatt, Deepak L., Bittner, Vera A., Danchin, Nicolas, Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Liberopoulos, Evangelos, Marx, Nikolaus, McGinniss, Jennifer, Manvelian, Garen, Pordy, Robert, Scemama, Michel, White, Harvey D., Zeiher, Andreas M., Schwartz, Gregory G.

Volltext

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment von Schwartz, Gregory G., Szarek, Michael, Bittner, Vera A., Bhatt, Deepak L., Diaz, Rafael, Goodman, Shaun G., Jukema, J. Wouter, Loy, Megan, Manvelian, Garen, Pordy, Robert, White, Harvey D., Steg, Philippe Gabriel

Volltext

PB1249 Prospective, Observational Study of the Clinical Characteristics of Adults and Adolescents with Severe Hemophilia A von Chowdary, P., Khoo, L., Wang, M., Chambost, H., Chan, A., Moryusef, A., Willemze, A., Oldenburg, J.

Volltext

Effect of Alirocumab on Mortality After Acute Coronary Syndromes von Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Brégeault, Marie-France, Dalby, Anthony J, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Vogel, Robert, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G

Volltext

P1226Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES von Schwartz, G, Szarek, M, Li, Q H, Chiang, C E, Diaz, R, Hagstrom, E, Huo, Y, Jukema, J W, Lecorps, G, Moryusef, A, Pordy, R, White, H D, Yusoff, K, Zeiher, A M, Steg, P G

Volltext

Rapid onset and offset of action of otamixaban, a potent direct intravenous factor Xa inhibitor von Grosjean, P., Hurbin, F., Jan, C., Guo, Z., Moryusef, A.

Volltext

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome von Schwartz, G.G, Steg, P.G, Szarek, M, Bhatt, D.L, Bittner, V.A, Diaz, R, Edelberg, J.M, Goodman, S.G, Hanotin, C, Harrington, R.A, Jukema, J.W, Lecorps, G, Mahaffey, K.W, Moryusef, A, Pordy, R, Quintero, K, Roe, M.T, Sasiela, W.J, Tamby, J.-F, Tricoci, P, White, H.D, Zeiher, A.M, Aylward, Philip E, Drexel, Heinz, Sinnaeve, Peter, Dilic, Mirza, Lopes, Renato D, Gotcheva, Nina N, Goodman, Shaun G, Prieto, Juan-Carlos, Yong, Huo, Lopez-Jaramillo, Patricio, Pecin, Ivan, Reiner, Zeljko, Ostadal, Petr, Poulsen, Steen Hvitfeldt, Viigimaa, Margus, Nieminen, Markku S, Danchin, Nicolas, Chumburidze, Vakhtang, Marx, Nikolaus, Liberopoulos, Evangelos, Montenegro Valdovinos, Pablo Carlos, Tse, Hung-Fat, Kiss, Robert Gabor, Xavier, Denis, Zahger, Doron, Valgimigli, Marco, Kimura, Takeshi, Kim, Hyo Soo, Kim, Sang-Hyun, Erglis, Andrejs, Laucevicius, Aleksandras, Kedev, Sasko, Yusoff, Khalid, Ramos Lopez, Gabriel Arturo, Alings, Marco, Halvorsen, Sigrun, Correa Flores, Roger M, Sy, Rody G, Budaj, Andrzej, Morais, Joao, Dorobantu, Maria, Karpov, Yuri, Ristic, Arsen D, Chua, Terrance, Murin, Jan, Fras, Zlatko, Dalby, Anthony J, Tunon, Jose, de Silva, H. Asita, Hagstrom, Emil, Muller, Christian, Chiang, Chern-En, Sritara, Piyamitr, Guneri, Sema, Parkhomenko, Alexander, Ray, Kausik K, Moriarty, Patrick M, Vogel, Robert, Chaitman, Bernard, Kelsey, Sheryl F, Olsson, Anders G, Rouleau, Jean-Lucien, Simoons, Maarten L, Alexander, Karen, Meloni, Chiara, Rosenson, Robert, Sijbrands, Eric J.G, Alexander, John H, Armaganijan, Luciana, Bagai, Akshay, Bahit, Maria Cecilia, Brennan, J. Matthew, Clifton, Shaun, DeVore, Adam D, Deloatch, Shalonda, Dickey, Sheila, Dombrowski, Keith, Ducrocq, Gregory

Volltext

Cardiovascular Outcomes With Alirocumab After Acute Coronary Syndrome: Results of the Odyssey Outcomes Trial von White, H., Steg, P., Szarek, M., Bhatt, D., Bittner, V., Diaz, R., Edelberg, J., Goodman, S., Hantoin, C., Harrington, R., Jukema, J., Lecorps, G., Moryusef, A., Pordy, R., Roe, M., Zeiher, A., Schwartz, G.

Volltext

Use of High-Intensity Statin Therapy Post-Acute Coronary Syndrome in the Ongoing ODYSSEY OUTCOMES Trial of Alirocumab, A Proprotein Convertase Subtilisin/Kexin type 9 Monoclonal An... von White, H., Goodman, S., Schwartz, G., Bhatt, D., Bittner, V., Diaz, R., Hanotin, C., Harrington, R., Jukema, J., Moryusef, A., Pordy, R., Roe, M., Sasiela, W., Szarek, M., Tamby, J., Zeiher, A., Steg, P.

Volltext

Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers von Ragueneau, Isabelle, Michaud, Pierre, Démolis, Jean-Louis, Moryusef, Angèle, Jaillon, Patrice, Funck-Brentano, Christian

Volltext

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES r... von Ray, KK, Colhoun, HM, Szarek, M, Baccara-Dinet, M, Bhatt, DL, Bittner, VA, Budaj, AJ, Diaz, R, Goodman, SG, Hanotin, C, Harrington, RA, Jukema, JW, Loizeau, V, Lopes, RD, Moryusef, A, Murin, J, Pordy, R, Ristic, AD, Roe, MT, Tunon, J, White, HD, Zeiher, AM, Schwartz, GS, Steg, PG

Volltext

E058 Mibefradil, new T-channel calcium blocker, is more efficient to decrease the diastolic diurnal blood pressure than hydrochlorothiazide or enalapril in elderly hypertensive von Forette, B., Moulias, R., Vaisse, B., Moryusef, A., Darné, B., Koen, R.

Volltext

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes : rationale and design of the ODYSSEY Outcomes trial von Schwartz, Gregory G

Volltext bestellen

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial von Schwartz, Gregory G., MD, PhD, Bessac, Laurence, MD, Berdan, Lisa G., PA, MHS, Bhatt, Deepak L., MD, MPH, Bittner, Vera, MD, Diaz, Rafael, MD, Goodman, Shaun G., MD, MSc, Hanotin, Corinne, MD, Harrington, Robert A., MD, Jukema, J. Wouter, MD, PhD, Mahaffey, Kenneth W., MD, Moryusef, Angèle, MD, Pordy, Robert, MD, Roe, Matthew T., MD, MPH, Rorick, Tyrus, RN, Sasiela, William J., PhD, Shirodaria, Cheerag, MBBS, Szarek, Michael, PhD, Tamby, Jean-François, MD, Tricoci, Pierluigi, MD, White, Harvey, MBBS, DSc, Zeiher, Andreas, MD, Steg, Philippe Gabriel, MD

Volltext

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial von Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Brégeault, Marie-France, Dalby, Anthony J, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Vogel, Robert, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G

Volltext